Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.
Masimo's MightySat Medical is the first FDA-cleared pulse oximeter available to consumers without a prescription, which could disrupt the market for the notoriously inaccurate at-home devices.
MediView’s technologies utilize AR to provide clinicians with 3D “X-ray vision” guidance during minimally invasive procedures and surgeries, while also offering remote collaboration.
As an academic AI expert, Pascale Fung, PhD, dove into the scientific research when she was diagnosed with breast cancer in 2015. The time investment rewarded her with a depth of understanding that has helped shape her life as a cancer survivor.
Researchers have found that spiking neural networks become unstable after unbroken periods of unsupervised self-training. Moreover, these “artificial brains” seem to restabilize after they’re given the equivalent of a good night’s rest.
AI is stepping in to help speed up the diagnosis of COVID-19 and expedite how much time healthcare professionals spend determining COVID-19 pneumonia and non-COVID-19 cases.
The World Health Organization announced it will resume a clinical trial evaluating the efficacy of hydroxychloroquine for COVID-19 patients after the organization halted it following studies showing higher risks to patients taking the drug.
U.S. Army researchers are calling for the creation of a national emergency network that would coordinate select digital health technologies, including AI, in fighting COVID-19 now and other public health crises later.
The Lancet has issued four corrections to a research paper that found COVID-19 patients who used the drug hydroxychloroquine have a higher risk of death.
Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.
When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country.
If passed, this bill would help clinician-led clinical registries explore Medicare data for research purposes. The Society of Thoracic Surgeons and American College of Cardiology both shared public support for the bipartisan legislation.